| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/07/2013 | WO2013030366A1 Novel soft rock inhibitors |
| 03/07/2013 | WO2013030365A1 Novel rock kinase inhibitors |
| 03/07/2013 | WO2013030150A1 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines |
| 03/07/2013 | WO2013030138A1 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | WO2013030058A1 Use of diclofenac |
| 03/07/2013 | WO2013029525A1 Pharmaceutical composition comprising iodine polymer and glucocorticosteroid for treating dermatitis |
| 03/07/2013 | WO2013029338A1 Novel compounds |
| 03/07/2013 | WO2013009519A3 Materials for treating and preventing mucosa related disease |
| 03/07/2013 | WO2012159593A9 A combined oral formulation with controlled release of acetylsalicylic acid and a method for the preparation |
| 03/07/2013 | US20130060235 Pharmaceutical compositions and methods of use |
| 03/07/2013 | US20130059915 Treatment of pain with topical diclofenac |
| 03/07/2013 | US20130059910 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders |
| 03/07/2013 | US20130059883 Compounds and methods |
| 03/07/2013 | US20130059878 Treatment of diseases modulated by a h4 receptor agonist |
| 03/07/2013 | US20130059871 Pyrimidine derivatives for the treatment of amyloid-related diseases |
| 03/07/2013 | US20130059869 Methods and compositions for treating disorders |
| 03/07/2013 | US20130059868 Treatment of gout |
| 03/07/2013 | US20130059850 Aza-indole derivatives useful as modulators of faah |
| 03/07/2013 | US20130059848 Cannabinoid-2 agonists |
| 03/07/2013 | US20130059847 Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
| 03/07/2013 | US20130059845 Bicyclic agonists of gpr131 and uses thereof |
| 03/07/2013 | US20130059843 Thiazolyl- and Oxazolyl-Isoquinolinones and Methods for Using Them |
| 03/07/2013 | US20130059842 Manufacturing of quick release pharmaceutical compositons of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 03/07/2013 | US20130059839 Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use |
| 03/07/2013 | US20130059835 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | US20130059834 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | US20130059832 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059821 Bicyclic aryl sphingosine 1-phosphate analogs |
| 03/07/2013 | US20130059814 Anti-inflammatory dermatological composition comprising corticosteroids and hyaluronate fragments, and uses thereof |
| 03/07/2013 | US20130059807 Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| 03/07/2013 | US20130059801 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | US20130059788 Prodomain modulators of adam 10 |
| 03/07/2013 | US20130059770 Polypeptides |
| 03/07/2013 | US20130059769 Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications |
| 03/07/2013 | US20130059337 Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin |
| 03/07/2013 | US20130059019 Methods and compositions for treating inflammation of skin |
| 03/07/2013 | US20130059012 Methods for the Diagnosis, Control and Prophylaxis of Inflammation and Mitigation of Inflammatory Conditions in Felines |
| 03/07/2013 | US20130059009 Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriers |
| 03/07/2013 | US20130059004 Oral drug delivery system |
| 03/07/2013 | US20130058993 Methods and compositions for enhancing wound healing using car peptides |
| 03/07/2013 | US20130058985 Spray-Pumpable Composition Suitable for Topical Skin Application |
| 03/07/2013 | US20130058984 Single-walled carbon nanotube/bioactive substance complexes and methods related thereto |
| 03/07/2013 | US20130058978 Induced tolerogenic dendritic cells for inducing regulatory b cells |
| 03/07/2013 | US20130058977 Compositions and methods related to induced tolerogenic dendritic cells externally loaded with mhc class i-restricted epitopes |
| 03/07/2013 | US20130058975 Antigen-specific induced tolerogenic dendritic cells to reduce antibody responses |
| 03/07/2013 | US20130058974 Antigen-specific induced tolerogenic dendritic cells to reduce cytotoxic t lymphocyte responses |
| 03/07/2013 | US20130058972 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/07/2013 | US20130058970 Induced tolerogenic dendritic cells to reduce systemic inflammatory cytokines |
| 03/07/2013 | US20130058961 Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| 03/07/2013 | US20130058957 Dendritic cell immunoreceptor agonist |
| 03/07/2013 | US20130058956 Extracellular ifi16 as therapeutic agents |
| 03/07/2013 | US20130058943 Bovine polyclonal antibody specific for human tnf |
| 03/07/2013 | US20130058933 Monovalent ligands of the human cd28 receptor |
| 03/07/2013 | US20130058919 Optimized Fc Variants and Methods for their Generation |
| 03/07/2013 | US20130058917 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column |
| 03/07/2013 | US20130058912 Therapeutic Charge Engineered Variants of Lysozyme and Methods for Using Same to Treat Infections |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058892 Pyrimidinyl indole compounds |
| 03/07/2013 | US20130058880 Film forming personal care compositions and methods |
| 03/07/2013 | US20130058876 (trimethoxyphenylamino) pyrimidinyl formulations |
| 03/07/2013 | US20130058873 P97 fragments with transfer activity |
| 03/07/2013 | US20130058868 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo |
| 03/07/2013 | US20130058866 N-pyrazole a2a receptor agonists |
| 03/07/2013 | CA2847336A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847334A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847218A1 Formulations and dosage forms of oxidized phospholipids |
| 03/07/2013 | CA2847199A1 Products for anti-inflammation support |
| 03/07/2013 | CA2846752A1 Biphenylcarboxamides as rock kinase inhibitors |
| 03/07/2013 | CA2846695A1 Novel soft rock inhibitors |
| 03/07/2013 | CA2846694A1 Novel rock kinase inhibitors |
| 03/07/2013 | CA2846692A1 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines |
| 03/07/2013 | CA2846652A1 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | CA2846510A1 Choline salt of an anti - inflammatory substituted cyclobutenedione compound |
| 03/07/2013 | CA2846248A1 Method for inhibiting cellular activation by insulin-like growth factor-1 |
| 03/07/2013 | CA2845785A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2845169A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2845159A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2844730A1 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | CA2844464A1 Methods for treating properdin-related diseases or disorders |
| 03/06/2013 | EP2565269A1 High-purity soluble thrombomodulin and method for producing same |
| 03/06/2013 | EP2564857A1 Boron-containing small molecules as anti-inflammatory agents |
| 03/06/2013 | EP2564849A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 03/06/2013 | EP2563788A1 Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases |
| 03/06/2013 | EP2563787A1 Azaindazole amide compounds as ccr1 receptor antagonists |
| 03/06/2013 | EP2563782A1 Polymorphs of a metabotropic glutamate receptor positive allosteric modulator |
| 03/06/2013 | EP2563776A2 Compounds that modulate intracellular calcium |
| 03/06/2013 | EP2563774A1 Pyrimidinyl indole compounds |
| 03/06/2013 | EP2563759A2 Compounds that modulate intracellular calcium |
| 03/06/2013 | EP2563405A1 Selective integrin inhibitors |
| 03/06/2013 | EP2563383A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
| 03/06/2013 | EP2563382A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases |
| 03/06/2013 | EP2563381A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases |
| 03/06/2013 | EP2563380A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
| 03/06/2013 | CN202761909U Ginger medicine hot push capsule |
| 03/06/2013 | CN1826344B (1S, 5S)-3-(5, 6-dichloro-3-pyridinyl)-3, 6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
| 03/06/2013 | CN102958918A Novel nicotinamide derivatives or salts thereof |
| 03/06/2013 | CN102952678A Capillary wormwood herb eczema-treating health-care wine |
| 03/06/2013 | CN102952676A Kusnezoff monkshood mother-root cold hernia health-care wine |
| 03/06/2013 | CN102952671A Anti-rheumatism Siberian cocklebur fruit health-care wine |
| 03/06/2013 | CN102952670A Qi-activating and pain-relieving Mongollian thyme herb health wine |